 |
|
European Atherosclerosis Society Congress
81st EAS Congress
June 2-5, 2013, Lyon, France |
|
Decreased CRP levels in response to a six-week, once-daily oral insulin regimen |
|
Global Technology Community Diabetes Summit 2013
GTC Diabetes Summit 2013
April 29-30, 2013, Boston, MA |
|
Oral insulin capsules towards management of Type 1 diabetes mellitus |
|
ISA 2012
Sydney, Australia
March 25-29, 2012 |
|
Decreased CRP Levels in response to a six week, once-daily oral insulin regimen |
|
ADA 72nd Annual Scientific Sessions
Philidelphia, Pennsylvania
June 8-12, 2012 |
|
Concomitant oral insulin and exenatide therapies significantly curb postprandial glucose excursions in pigs |
|
12th Annual Diabetes Technology Society Meeting
Bethesda, MD
Nov 8-10, 2012 |
|
Concomitant oral and subcutaneous insulin therapy toward stabilization of uncontrolled Type 1 Diabetes Mellitus |
|
Diabetes Technology Meeting 2011
San Francisco, California
October 27-29, 2011 |
|
Evaluation of the Safety and Efficacy of Two Oral Insulin Formulations in Healthy Volunteers |
|
ILAF Project
|
September 2011 |
|
A Model of Long Term Intestinal Access in the Pigs |
|
Diabetes Technology Meeting 2011
Diabetes Technology Meeting
October 2011, San Francisco, CA |
|
Diabetes Technology Meeting 2011 |
|
Diabetes Technology Meeting 2010
Bethesda, Maryland
November 11-13, 2010 |
|
Extended exposure to an oral insulin formulation yields decreased insulin secretion in Type II diabetes subjects |
|
ADA 70th Annual Scientific Sessions
Orlando, Florida
June 25-29, 2010 |
|
Oral insulin: Type 1 Diabetes (T1DM) Patient Response Upon Preprandial Administration |
|
ADA 70th Annual Scientific Sessions
Orlando, Florida
June 25-29, 2010 |
|
A Single-Blind, Two-Period Study to Assess the Safety and Pharmacodynamics of an Orally Delivered GLP-1 Analog (Exenadite) in Healthy Subjects |
|
ADA 69th Annual Scientific Sessions
New Orleans, LA
June 5-9, 2009 |
|
Open-Label Study to Assess the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Oral Insulin Formulation in Subjects with Type 2 Diabetes (T2DM) |
|
9th Annual Meeting of Diabetes Technology Society
San Francisco, California
5-7th November, 2009 |
|
A novel GLP-1 Analog delivered orally reduces postprandial glucose excursions in a porcine model |
|
8th Annual Meeting of Diabetes Technology Society
Bethesda, Maryland
November 13-15, 2008 |
|
Enteral Administration of Exenatide-4; Proof of Concept Pharmacodynamic Study in Dogs |
|
ADA 68th Annual Scientific Sessions
San Francisco, California
June 6-10, 2008 |
|
Pharmacokinetics (PK) and Pharmacodynamics (PD) of Oral Insulin in Healthy Subjects |
|
44th Annual Meeting of the European Association for the Study of Diabetes (EASD)
Rome, Italy
September 7-11, 2008 |
|
Open Label Study to Assess the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Five Oral Insulin Formulations in Healthy Subjects |
|
|
|
